1st Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Support PAHPA reauthorization. Address concerns with changes to Medicare Part B and Part D programs.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpilefunding and preparation; FDA Appropriations.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.